Press Releases
CLSI Announces Risk Management Tools for Improved Patient Safety Workshop for 2006; CLSI and COLA Announce New Partnership

NEW:  Risk Management Tools for Improved Patient Safety Workshop Announced by Clinical and Laboratory Standards Institute
Wayne, PA, USA—1 November 2005—Clinical and Laboratory Standards Institute (CLSI, formerly NCCLS) has announced it will follow up March 2005’s groundbreaking Quality Control for the Future workshop with a workshop titled Risk Management Tools for Improved Patient Safety, to take place in conjunction with the organization’s annual Leadership Conference, from 26-28 April 2006 in Vienna, Virginia, outside of Washington, DC.  Risk Management Tools for Improved Patient Safety will focus specifically upon defining current problems in risk management, reviewing currently employed mechanisms and solutions, and describing a systematic risk management approach, providing attendees with concrete tools with which to return to their workplaces for practical application.
Full press release

NEW:  CLSI and COLA Announce New Partnership
Global standards-development organization Clinical and Laboratory Standards Institute (CLSI) and US laboratory accreditation leader COLA today announced a partnership that fits the respective missions of the two organizations, directly linking best practice standards, guidelines, and educational services to regulatory compliance and laboratory accreditation.   Under the agreement, CLSI will develop a collection of consensus documents specifically designed for the clinical laboratory, which complements COLA’s unique online education program on quality management systems. 
Full press release

NEW:  CLSI Guideline to Aid Labs in Detecting Error Caused by Interfering Substances
Measurement errors caused by interfering substances may put patients at risk.  Even while internal quality control systems to monitor precision, and reference materials or procedures can be used to verify accuracy, it remains a difficult task for laboratories to detect error caused by interfering substances.  Therefore, manufacturers of in vitro diagnostic (IVD) analytical systems must include evaluation of the effects of the potentially interfering substances in their risk analyses at the design stage.
Full press release

CLSI Receives Cooperative Agreement to Improve HIV Testing Worldwide
Global standards-development organization Clinical and Laboratory Standards Institute (CLSI, formerly NCCLS) has received a $365,000 USD cooperative agreement from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS/CDC) for capacity-building assistance for global HIV/AIDS laboratory guidelines and standards development.  The year-long agreement is funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), which the U.S. Department of State describes as “the largest commitment ever by a single nation toward an international health initiative.”
Full press release.

CLSI to Provide Standardized Testing Methods for Infrequently Encountered Bacteria
Clinical and Laboratory Standards Institute (CLSI, formerly NCCLS) has for years provided standardized methods for antimicrobial susceptibility testing (AST) of common aerobic bacteria, including some fastidious organisms or potential agents of bioterrorism.  CLSI has published AST guidelines for less frequently encountered or fastidious bacteria, which presently lack CLSI test methods and interpretive criteria, in the document Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Proposed Guideline (M45-P). 
Full press release.

CLSI Releases Guideline for Vital Newborn Screening Follow-up Activities
Newborn screening is a process by which over 10 million newborns worldwide are each year screened for congenital diseases, which must be detected early for the prevention of morbidity and mortality.  Rapid follow-up is an essential component of this vital public health activity.  Clinical and Laboratory Standards Institute (CLSI, formerly NCCLS) has published Newborn Screening Follow-up; Proposed Guideline (I/LA27-P), which describes the basic principles, scope, and range of follow-up activities within the newborn screening system. 
Full press release.

  [ return to top ]